2021 Investor Day
Propeller's strong value proposition in Respiratory Care
Value proposition
Enables increased data capture and analysis
Improves insight into patient adherence for physicians
-
-
Current adherence rates as low as 20% in COPD treatment
Studies show Propeller can increase adherence >58%
Helps patients identify potential triggers of acute symptoms
Seamlessly integrates the patient, physician, and their
pharmacy; data flows between us and our partners to
continuously improve the process
-
Proactive data-driven approach to COPD and asthma
treatment can drastically reduce occurrence and associate
costs of acute respiratory treatment
1Merchant, Rajan, et al. "Impact of a digital health intervention on asthma resource utilization." World Allergy Organization Journal 11.1 (2018): 28.
ED: Emergency Department
© 2021 ResMed | 2021 Investor Day - Sept 8, 2021
Events per 100 patients
Reduced acute care utilization with Propeller1
13
12
CO
6
5
Pre-enrollment
Post-enrollment
2
0
ED + Hosp.
ED
Hosp.
Positive momentum in the market
38View entire presentation